TAR-200 for Bacillus Calmette-Guérin–Unresponsive High-Risk Non–Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study A total of 527 patients were enrolled, with 426 included in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback